Category Archives: News
High end, multi-spectral 3D tissue imaging with our C-Direct tagged anti-NCAM VHH Q55c

A recent study by Ravian van Ineveld and Michiel Kleinnijenhuis et al. in Nature Biotechnology shows the development of a new method for determining molecular, spatial and morphological features of cells in 3D tissues. The research group led by dr. Anne Rios (Princess Máxima Center for pediatric oncology, Oncode Institute) developed an eight-color, multispectral, Large-scale Single-cell […]

Health Holland PPP consortium to develop clinically-validated models for high throughput testing of COVID-19 drug candidates

The current COVID-19 pandemic, caused by coronavirus SARS-COV-2, has made a huge impact on health, health care systems, social interactions and the economy. Importantly, anti-viral therapeutics that directly limit or prevent viral replication are lacking. In a new TKI-LSH public private partnership project by Health Holland entitled ‘CLEAR COVID-19’, laboratories from the University Medical Center […]

ENW-PPS TA funding for multidisciplinary project MAGNETIC on CXCR4

NWO has granted one of the Scientific public private partnership (PPS) Technology Area (TA) funds to Martine Smit (AIMMS, Vrije Universiteit, Division of Medicinal Chemistry) and collegues from Utrecht University (Wei Wu), the Amsterdam UMC (Arnon Kater) and the two SMEs QVQ (Raimond Heukers) and Argenx (Hans de Haard). This public private partnership project is […]

NWO grants KIEM project for development of VHH-based cancer vaccins

NWO granted 11 KIEM (Kennis Innovatie Mapping) funds as part of their scientific PPP calls. One of these grants was awarded to Dr. Joke den Haan of the department of Molecular Cell Biology and Immunology at the Amsterdam UMC and Raimond Heukers of QVQ Holding BV to co-develop VHH-based cancer vaccins. In this project, new […]

QVQ actively participates in the next European Training Network on oncogenic GPCRs: ONCORNET 2.0.

The European Union has granted 4 M euro to Martine Smit and Jacqueline van Muijlwijk (Medicinal Chemistry, AIMMS, Faculty of Science, Vrije Universiteit Amsterdam) and colleagues from academia and SMEs from the Netherlands, France, Germany, Spain, UK and Switzerland to train young scientist to become experts in oncogenic GPCR research. ONCORNET2.0 builds on the success […]

QVQ partners up with Suzan Rooijakkers (UMCU) to target the complement system with a granted NWO Industrial Doctorate

NWO has funded sixteen PhD projects through their Industrial Doctorate program. One of these grants was awarded to Suzan Rooijakkers (UMC Utrecht) and QVQ to target neoepitopes on C5 convertases using VHHs. These C5 convertases are key enzymes in an overactive immune system, an underlying cause of many inflammatory diseases. The industrial doctorate PhD student […]

New: QVQ Holding b.v. was present at the 14th European Molecular Imaging Meeting from March 19-22 in Glasgow. Raimond Heukers presented the development of the C-Direct tag for the directional conjugation of VHH to imaging molecules

You can now download our new poster on Site-directional functionalization of VHH using the C-direct tag. Click here to download.

Substantial grant from EU and Op Oost [NL] to develop VHH to detect and repair Osteoarthritis

QVQ Holding b.v. as partner of a larger consortium  and in collaboration with its daughter company Orthros TR b.v. -has received a substantial grant from EU and Op Oost [NL] to develop VHH to detect and repair Osteoarthritis, an age related disease affecting over 100.000.000 people around the globe [see our products in this area]. […]

Patent to combat Candidiasis with lama antibodies [VHH]

QVQ Holding b.v. and Hans Knoll Institute in Jena [Germany] have filed a patent to combat Candidiasis  with lama antibodies [VHH]. Candidiasis is caused by Candida albicans and infection with C. albicans can be life threatening when entering the blood stream. By filing this patent QVQ strengthens its leading position in the development of VHH […]

QVQ holding has joined the Biotech Investissement group and is now a sister company of RD-Biotech SAS, Diaclone SAS and SynAbs SA (

We are pleased to announce that QVQ holding has joined the Biotech Investissement group and is now a sister company of RD-Biotech SAS, Diaclone SAS and SynAbs SA ( RD-Biotech is a well experienced CRO which supplies high quality custom services in biomanufacturing (plasmids, monoclonal antibodies and recombinant antibodies, recombinant proteins, cells) and research contracts […]